- NCIt
- C3641
- MeSH
- D000071960
Loading cancer entity…
Loading cancer entity…
Clinical trials
194 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (30)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06033092 | Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion(TOLERANT) | completed | Phase 2 | 110 | European Institute of OncologyOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT06234488 | Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study | completed | — | 125 | Medical College of WisconsinOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT05545150 | Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study | completed | Phase 2 | 113 | Northwestern UniversityOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT00165256 | Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast | completed | Phase 2 | 157 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT05900986 | LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer | completed | Phase 1 / Phase 2 | 22 | Integro TheranosticsINDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT02928978 | Ruxolitinib for Premalignant Breast Disease(TBCRC042) | completed | Phase 2 | 84 | Julie NangiaOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05263362 | An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)(STARLINGS) | completed | — | 775 | Erasmus Medical CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06133465 | Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management | completed | — | 1,063 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06133647 | Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System | completed | — | 8 | Methodist Health SystemOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06335108 | Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 ) | completed | — | 349 | University Hospital TuebingenOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT06388304 | THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence(THRIVE) | completed | N/A | 39 | Joanna ArchOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT03345420 | Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer(NOVEMBER) | completed | Phase 2 | 102 | University of UtahOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT00757302 | Intraoperative Gamma Camera for Breast Cancer Surgery | completed | Phase 3 | 110 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT04999917 | Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer(BrIMA) | completed | N/A | 206 | XEOS MedicalINDUSTRY | 1 | Dec 5, 2025 | clinicaltrials |
| NCT01841749 | Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast(CINNAMOME) | completed | — | 228 | Institut BergoniéOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT00769379 | Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy | completed | Phase 3 | 2,014 | National Cancer Institute (NCI)NIH | 4 | Jun 12, 2025 | clinicaltrials |
| NCT01819233 | Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy(CAREFOR) | completed | N/A | 38 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT05086705 | EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer | completed | N/A | 50 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT00605982 | Breast MRI as a Preoperative Tool for DCIS | completed | N/A | 115 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05012176 | An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors | completed | N/A | 50 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT02694809 | The PROMISE Study: Duavee in Women With DCIS | completed | Phase 2 | 142 | Northwestern UniversityOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT04365114 | Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening(POSTBOx) | completed | — | 13,094,122 | University of WarwickOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT03375892 | The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure | completed | N/A | 11 | Medical College of WisconsinOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT02993159 | Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast | completed | Phase 2 | 100 | Northwestern UniversityOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT04245150 | Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity | completed | — | 23 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01706432 | Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | completed | — | 4 | University of ChicagoOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05946759 | Reoperation Rate in Breast-Conserving Surgery Using Confocal Histolog® Scanner for Intraoperative Margin Assessment(SHIELD) | completed | N/A | 54 | SamanTree Medical SAINDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT02636582 | Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Dec 5, 2023 | clinicaltrials |
| NCT01219075 | Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer | completed | N/A | 110 | University of Southern CaliforniaOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT01628536 | A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ | completed | N/A | 33 | Yale UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT02637024 | Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation(OPAR) | completed | Phase 2 | 280 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT04022772 | Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | completed | N/A | 287 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05961280 | Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates | completed | — | 385 | Gangnam Severance HospitalOTHER | 0 | Jul 27, 2023 | clinicaltrials |
| NCT02121873 | The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage | completed | — | 6 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jul 20, 2023 | clinicaltrials |
| NCT02526498 | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery(TRIUMPH-T) | completed | Phase 2 | 200 | Rutgers, The State University of New JerseyOTHER | 1 | May 15, 2023 | clinicaltrials |
| NCT02314156 | Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | completed | Phase 2 | 67 | Northwestern UniversityOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04248179 | The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | completed | Phase 4 | 36 | Zealand University HospitalOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT03775213 | Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) | completed | N/A | 322 | Duke UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT03323658 | Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2023 | clinicaltrials |
| NCT04170920 | Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs | completed | N/A | 62 | Indiana UniversityOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT04866992 | Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)(SPrNSM) | completed | — | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT01849250 | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Dec 28, 2021 | clinicaltrials |
| NCT04245657 | Factors Affecting Functionality in Breast Cancer Survivors | completed | — | 111 | Izmir Bakircay UniversityOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03834532 | Living Well After Breast Surgery | completed | N/A | 17 | University of Texas at AustinOTHER | 1 | Nov 2, 2021 | clinicaltrials |
| NCT03931928 | Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients(TAMENDOX) | completed | Phase 2 | 356 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)OTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT01448447 | Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®(Mammosite ML) | completed | N/A | 20 | Mercy ResearchOTHER | 1 | Jul 15, 2021 | clinicaltrials |
| NCT01023477 | Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) | completed | Phase 1 / Phase 2 | 12 | Inova Health Care ServicesOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT00256217 | Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women | completed | Phase 2 | 42 | Rita Sanghvi, MehtaOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT00496808 | Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | completed | N/A | 69 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT02061332 | DC Vaccine for Patients With Ductal Carcinoma In Situ(DCIS6) | completed | Phase 1 / Phase 2 | 58 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2020 | clinicaltrials |
Data updated 19 days agoSource updated Sep 11, 2026source: clinicaltrials